BM

Bharatchandra Mohanlal Desai

Active Director Director DIN 11595728
DIN 11595728 First appointment Mar 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Bharatchandra Mohanlal Desai

Data last updated:

Bharatchandra Mohanlal Desai is a Director at Radyus Sciences Private Limited (since 2026). The company operates in Pharma.

DIN 11595728
Primary Designation Director
Industry Pharma
First Appointment 10 Mar 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Radyus Sciences Private Limited U21001GJ2026PTC174644
Director10 Mar 20262026Active

Board colleagues of Bharatchandra Mohanlal Desai

NameDINCompanyDesignation
Charulata Mukesh Desai11595729Radyus Sciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Radyus Sciences Private Limited
Premium access

Shareholding and investment profile for Bharatchandra Mohanlal Desai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bharatchandra Mohanlal Desai

Bharatchandra Mohanlal Desai currently holds 1 directorship: Radyus Sciences Private Limited (Director, since 10 Mar 2026).

Bharatchandra Mohanlal Desai was first appointed on 10 Mar 2026 as Director at Radyus Sciences Private Limited.

The current boards of Bharatchandra Mohanlal Desai's companies include Charulata Mukesh Desai (Radyus Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available